Lychee Litchi Chinensis.

Ascorbate reduces the phenoxyl radicals left behind when lychee proanthocyanidins quench an oxidant, returning them to their active form. The two sit at different points of the same aqueous radical handling chain.

Tocopherol handles lipid phase radicals inside membranes while lychee polyphenols act in the water phase, and polyphenols help regenerate the tocopheroxyl radical at the membrane surface. The pairing covers both compartments rather than doubling up on one.

Lychee oligonol is a low molecular weight proanthocyanidin, the same flavan-3-ol family grape seed supplies at higher polymer size. Absorption falls sharply as chain length rises, so combining the two spreads the oligomer sizes presented to the gut.

Both deliver procyanidin oligomers that gut bacteria metabolise to the same phenolic acids. Formulators pair them to spread the oligomer profile across a wider size range.

Lychee flavanols and quercetin are both handled by intestinal and hepatic sulfotransferases and UGT enzymes, so each occupies conjugation capacity the other would otherwise use. Competing for that capacity can leave more of either aglycone unconjugated at first pass.

Galloylated polyphenols in lychee bind ferric iron in the gut lumen and form complexes the enterocyte cannot take up. Taking an iron dose at a separate time from a polyphenol rich extract avoids the loss.

An oligomerised litchi polyphenol has been reported to act on branched-chain amino acid transport and turnover, which places it upstream of how leucine is taken into tissue rather than beside it. That is a mechanistic finding, not an outcome. Anyone reading it as a muscle claim is going further than the report does.

Whey is the usual dietary source of leucine, isoleucine and valine, and litchi polyphenol work touches how those amino acids are transported and catabolised. Pairing them in a recovery formula follows that logic. The evidence behind it is mechanistic and does not establish a joint effect in people.

Litchi polyphenols are procyanidins built from catechin and epicatechin units, the same monomer family as green tea flavan-3-ols. Both are absorbed as monomers and small oligomers, conjugated in the gut wall and liver, and further broken down by colonic bacteria. Several standardised litchi preparations are in fact blended with green tea catechins, so the pairing is formulation reality as much as biochemistry.

Catechol and galloyl groups on flavanols bind divalent metals, forming complexes that are less available for uptake. That is the same chemistry behind tea reducing non-heme iron absorption, and zinc is affected by it too. Separating a high-polyphenol dose from a mineral dose by a couple of hours is the standard practical answer.

Copper is redox-active and readily complexed by polyphenol catechol groups, which is why polyphenols behave as metal chelators in solution. In the gut this can reduce the fraction of a copper dose available for absorption. The same binding is what limits copper-driven oxidation in a food matrix, so the effect cuts both ways depending on where it happens.

Flavanols donate hydrogen atoms to radicals and are left as semiquinone radicals that need reducing back. Dihydrolipoic acid is a strong reductant that participates in that regeneration network across both water and lipid compartments. The network chemistry is settled; the specific pairing has no combination trial here.

Litchi flavanols are water-soluble and act mainly in plasma and the aqueous compartments, while astaxanthin spans the lipid bilayer. Products aimed at skin appearance often pair one of each on that reasoning. It is compartment logic, not a measured interaction.

Collagen peptides supply glycine, proline and hydroxyproline plus the di- and tripeptides that reach circulation, while polyphenols act on oxidative and vascular biology in the dermis. The two do not overlap mechanically, which is the argument for combining them. Neither the pairing nor its skin effect is established in the sources available here.

Hyaluronic acid works on the water-binding capacity of the dermal matrix; litchi polyphenols are used for their antioxidant and microvascular reasoning. They sit in the same product category with different mechanisms. Support for the combination is formulation convention rather than evidence.

Citrulline raises plasma arginine, the substrate nitric oxide synthase uses. Flavanols are associated with better endothelium-dependent vasodilation, partly through nitric oxide availability rather than substrate supply. Because one adds substrate and the other affects the enzyme environment, they are not redundant; that reasoning has not been tested as a pair here.

Dietary nitrate is reduced by oral bacteria to nitrite and then to nitric oxide, a route independent of nitric oxide synthase. Flavanols contribute through the enzymatic route and by limiting oxidative loss of nitric oxide. The convergence is well described in the polyphenol literature; the specific combination with litchi is not measured here.

Resveratrol and litchi flavanols are both extensively glucuronidated and sulfated in the intestinal wall and liver, and both are metabolised further by colonic bacteria. Combining them loads the same phase II capacity, which can cut either way for the plasma level of each. It is worth stating as a shared-handling relationship rather than a straightforward addition.

Curcuminoids and flavanols are both heavily conjugated before they reach systemic circulation, and both are used for antioxidant and comfort-related positioning. Formulas often combine them for breadth of polyphenol coverage. The competition for conjugating enzymes is the reason the two are not simply additive.

Creatine works on phosphocreatine resynthesis and cellular hydration; litchi polyphenol interest in exercise contexts is about oxidative stress and amino acid handling. Nothing overlaps, so a formula can carry both without redundancy. No combination evidence is available here, and the recovery framing rests on mechanism.